Foreign Drug Giants Continue Expansion Into China, AstraZeneca Leads
This article was originally published in PharmAsia News
Executive Summary
Offering low-cost local drug manufacturing and clinical trials and a broader foundation for basic research, many foreign drug companies continue to expand into China, establishing offices in Shanghai